
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
What's A Decent FICO rating?
A definitive Bike Standoff: Decision in favor of Your Number one Ride
The most effective method to Make a Dazzling Site in 5 Basic Advances
Wisconsin archaeologists identify 16 ancient canoes in a prehistoric lake 'parking lot'
41 Young Men Die in South Africa After Circumcision Initiation
New Jordan security fence could be done in early 2028
Interstellar comet 3I/ATLAS' journey through our solar system, in photos
Which Espresso Do You Like Best? Vote
CDC vaccine panel delays vote to stop recommending hepatitis B shot at birth













